Global Stem Cells Group Names Enrique Testart, M.D. Chief Medical Officer

Global Stem Cells Group has named Enrique Testart, M.D., to the position of Chief Medical Officer for the Miami-headquartered biotech company.
MIAMI, Dec. 22, 2015—Global Stem Cells Group CEO Benito Novas announced the appointment of Enrique Testart, M.D. as Chief Medical Officer (CMO) of the international biotech company. Testart is a surgeon specializing in child trauma microsurgery. Testart is also a medical entrepreneur and founder of Consortia Innovas, SA in Santiago, Chile, a company dedicated to consulting and clinical health management for clinical management firms and research and development-oriented planners in the latest treatments in regenerative medicine as they become available.
Testart is the latest addition to GSCG’s recent string of high profile appointments including Novas as company CEO, Kipp Van Camp, D.O. as Chief Operating Officer, and Alfredo Hoyos, M.D. as head of the GSCG Advisory Board. According to Novas, the appointments mark Global Stem Cell Group’s exponential growth in Latin American and worldwide.
Testart, a native of Santiago, earned a medical degree from the University of Chile in Santiago, and began practicing medicine in a rural Chile hospital. He returned to Santiago to accept a fellowship at the Dr. Exequiel González Cortéz  Hospital,  part of Chile’s public health network.
He traveled to northeastern France in the 1980s to study orthopedics under the direction of Prof. Dr. Jean Paul Metaizeau. Testart remained in the region to specialize in microsurgery at Belle Isle Mertz Hospital, and while in France he began treating children with congenital musculoskeletal diseases such as osteogenesis imperfecta (brittle bone disease). Upon returning to Chile, Testart resumed his education to further study the embrochage centro médullaire élastique stable (E.C.M.E.S.) techniques he had studied under Metaizeau, which have become a standard worldwide for treating children with normal fractures, as well as those suffering from the spontaneous fractures caused by brittle bone disease.
Testart established a private medical practice in Santiago, founded the Association of Relatives of Patients with Osteogenesis Imperfecta, and began studying cell therapy research underway in Scandinavia. In 2000, Testart was tracking treatments with the latest technology in regenerative therapy, cell regeneration and isolation of mesenchymal stem cells from bone marrow while developing techniques and protocols to manage musculoskeletal disorders.
He trained further at the Domenikus Krankennouse Clinic in Germany and XCell Centers in London, Netherlands and Germany. He expanded the institution’s practice to Chile, acting as a consultant to various health organizations and doctors in a joint search for innovative medical solutions for orthopedic diseases and disorders. Gradually, he incorporated elements of regenerative medicine therapies into his own protocols, and went on to become the founder of the Institute of Advanced Cell Medicine and Bioengineering SAP, dedicated to the training, implementation and application of therapy tissue regeneration.
Testart is a consultant for the German Clinic of Santiago, San Cristobal Clinic Foundation, Stem Cells and Stem Cells Center at the Providence Marriott Center in Santiago, and is responsible for compiling reports and presenting them in Chile and Latin American countries.
After completing internships in the US and Mexico, Testart established The Institute, a group of organizations designed to meet the different needs of a new generation of medical consumers. With more than 20 years in the public and private sectors, the group of companies specializes in designing custom B2B and B2C programs for each central or regional organization model, providing innovative services and diagnostic accuracy to communities throughout Chile according to local needs.
Testart represents all Global Stem Cells Group divisions and programs in Chile, including patient recruitment through Cellgenic, and all responsibilities related to the sale of equipment disposable through Adimarket. He also oversees medical training and certification through Stem Cell Training Inc., with centers in three regions of Chile and plans to double that number in 2016.
Cellgenic, Stem Cell Training, Inc. and Adimarket are all subsidiaries of Global Stem Cells Group.
For more information, visit the Global Stem Cells Group website, email bnovas@stemcellsgroup.com, or call 305-560-5337.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies. each dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
###